From July 1, 2023 to September 30, 2023, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 0 shares, representing 0% for CNY 0 million under the buyback announced on January 31, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.71 CNY | -0.42% | -5.61% | -14.83% |
1st Jan change | Capi. | |
---|---|---|
-14.83% | 46Cr | |
+19.64% | 4.33TCr | |
+21.25% | 2.22TCr | |
+18.92% | 1.54TCr | |
+53.19% | 1.27TCr | |
-0.05% | 678.76Cr | |
-11.11% | 670.81Cr | |
-8.87% | 572.55Cr | |
+14.68% | 549.79Cr | |
+6.91% | 478.4Cr |
- Stock Market
- Equities
- 603669 Stock
- News Lionco Pharmaceutical Group Co.,Ltd.
- Tranche Update on Lionco Pharmaceutical Group Co.,Ltd.'s Equity Buyback Plan announced on January 31, 2023.